Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21365243 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed
Condition: Upper Gastrointestinal Bleed
Intervention: Drug: Pantoprazole
2 Suspended Proton Pump Inhibitor Use is Associated With High Risk of Pneumonia in Chronic Kidney Disease Patients
Conditions: Chronic Kidney Disease;   Pneumonia

Indicates status has not been verified in more than two years